Daejeon, South Korea

Han Seok Koh

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Han Seok Koh in Micellar Nanoparticles

Introduction

Han Seok Koh is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of nanotechnology, particularly in the development of micellar nanoparticles. His innovative work focuses on creating effective drug delivery systems that can enhance therapeutic outcomes.

Latest Patents

Han Seok Koh holds a patent for "Micellar nanoparticles and uses thereof." This patent includes cationic carrier units that consist of a water-soluble polymer, a positively charged carrier, and an adjuvant moiety. When mixed with an anionic payload, such as an antisense oligonucleotide, the composition self-organizes into a micelle that encapsulates the anionic payload in its core. The cationic carrier units can also feature a tissue-specific targeting moiety displayed on the micelle's surface. This innovation has potential applications in pharmaceutical compositions and methods for treating various diseases.

Career Highlights

Han Seok Koh is associated with Biorchestra Co., Ltd., where he continues to advance his research in nanotechnology and drug delivery systems. His work is characterized by a commitment to improving the efficacy of treatments through innovative delivery mechanisms.

Collaborations

Han Seok Koh collaborates with talented individuals such as Jin-Hyeob Ryu and Yu Na Lim. Their combined expertise contributes to the advancement of research and development in their field.

Conclusion

Han Seok Koh's contributions to the field of micellar nanoparticles represent a significant advancement in drug delivery technology. His innovative approach has the potential to improve treatment outcomes for patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…